Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Nov 2016 for Esperion Therapeutics, Inc., €45k.
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Narendra D. Lalwani: trading record in brief
Only one filing by Narendra D. Lalwani is known so far (3 November 2016): an open-market purchase, €45k, in Esperion Therapeutics, Inc. That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Narendra D. Lalwani
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 5,000 shares@ US$9.93100.0% of flowCommon StockSEC:0001179110-16-031173:0Canonical exit: 30 Jan 2017 (T+90)
1 of 1 declaration
